SOURCE: slp3D

November 09, 2006 17:01 ET

ORLive Presents: Cook's Zenith AAA Endovascular Graft -- Live Webcast to Japanese Physicians Demonstrates Use of First AAA Endograft Approved for Sale in Japan

Live Webcast November 16, 2006 at 6:00 PM EST (November 17, 2006 at 8:00 AM Tokyo Time)

NEW YORK, NY -- (MARKET WIRE) -- November 9, 2006 -- Japanese physicians who until recently have not had access to a commercial device for endovascular repair of abdominal aortic aneurysms (AAA) will be introduced to Cook's Zenith AAA Endovascular Graft, the world's top-selling device of its kind, in a live webcast on OR Live.com. The webcast, demonstrating the repair of a AAA with the Zenith AAA Endovascular Graft, will broadcast live from the Veith Symposium in New York, NY USA. This unique program will be available for live viewing at 8 a.m. Friday, November 17th Tokyo time. Cook's Zenith endograft recently became the first and only device of its type approved for endovascular repair of AAA in Japan -- one of the world's most important medical markets.

The case will be performed and discussed by the following team of doctors: Roy K. Greenberg, M.D., Director of the Endovascular Research Department of Vascular Surgery, Cleveland Clinic, Cleveland, Ohio USA; Takao Ohki, M.D., Professor in the Department of Surgery, Jikei University Hospital, Tokyo, Japan; Kimihiko Kichikawa, M.D., Department of Radiology, Nara Medical University, Nara, Japan; and Satoshi Kawaguchi, M.D., Department of Vascular Surgery, Tokyo Medical University, Tokyo, Japan.

"Cook is very pleased to be able to offer Japan this proven, life-saving medical device technology, " said Barry Thomas, global leader of Cook's Endovascular Therapies division.

Cook's Zenith AAA Endovascular Graft system permits treatment of abdominal aortic aneurysms without the need for major open surgery. The graft is made from a woven polyester graft material that is lightweight, strong and shrink-resistant and includes suprarenal fixation with anchoring barbs to ensure maximal stability and graft-to-vessel sealing. In addition, the H&L- B One-Shot Introducer System allows simple and accurate deployment and positioning of the graft and the Zenith design. Over 19,000 devices have been implanted in 2006. Dr. Greenberg is a paid consultant to Cook Incorporated who receives royalties for the sale of the Zenith device.

Cleveland Clinic does not endorse any products or companies. Dr. Greenberg receives research support, consulting fees and has intellectual property licensed to the sponsor of this program, Cook Incorporated (COOK). In addition, both Dr. Greenberg and the Cleveland Clinic receive royalty payments from Cook in connection with the sales of one of its products not described in this program.

http://www.or-live.com/cookzenithaaa/1471

Program Preview: http://www.or-live.com/rams/coi-1471-mkw-q.ram

Contact Information

  • Contacts:
    Meghan Freeman
    Public Relations Associate
    Cook Inc.
    (812) 339-2235, ext. 2418
    Email Contact

    Alex Fraser
    Director of Marketing
    OR-Live / slp3D, Inc
    860-953-2900 x 214
    Email Contact